Skip to content

Clinical trials

Phase 2/3 Immune System Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immune System Diseases Phase: Phase 2/3 Clear all

4 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20111
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed1
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AO GENERIUM1
Centre Hospitalier du Centre du Valais1
Masonic Cancer Center, University of Minnesota1
National Center for Research Resources (NCRR)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immune System Diseases4
Angioedema1
Angioedemas, Hereditary1
Arthritis1
Chediak-Higashi Syndrome1
Communicable Diseases1
Connective Tissue Diseases1
Genetic Diseases, Inborn1
Hematologic Diseases1
Histiocytosis, Langerhans-Cell1

Trials

Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.